Article

ACCC Publication Offers Insight for Incorporating Immunotherapies Into Practice

The Association of Community Cancer Centers (ACCC) has released a new report highlighting resources developed by the ACCC Immuno-Oncology Institute to meet the needs of detailed, practical insights for selecting and delivering immunotherapy, recognizing and managing immune-related toxicities, and coordinating patient care across specialties.

The Association of Community Cancer Centers (ACCC) has released a new report highlighting resources developed by the ACCC Immuno-Oncology Institute to meet the needs of detailed, practical insights for selecting and delivering immunotherapy, recognizing and managing immune-related toxicities, and coordinating patient care across specialties. Targeted materials developed by the institute include a how-to guide for developing an interdisciplinary toxicity team to help manage immune-related adverse events, as well as workshops and webinars focused on effective practices for multidisciplinary teams delivering these new therapies.

See more highlights from the report.

Related Videos
Mike Fazio, Navista, Cardinal Health
Dr Kimlin Tam Ashing
Andrew Kuykendall, MD, Moffitt Cancer Center
John Michael O'Brien, PharmD, MPH
Frederick L Locke, MD, Moffitt
Sam Peasah, PhD, MBA, RPh, director for the Center of High-Value Health Care at the University of Pittsburgh Medical Center (UPMC)
Erin Weber, MS
Cathy Eng, MD, FACP, FASCO, Vanderbilt-Ingram Cancer Center
Sam Peasah, PhD, MBA, RPh, director for the Center of High-Value Health Care at the University of Pittsburgh Medical Center (UPMC)
Erin Weber, MS
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo